Adrenocortical carcinoma: Past, present, and future Journal Article


Authors: LaFemina, J.; Brennan, M. F.
Article Title: Adrenocortical carcinoma: Past, present, and future
Abstract: Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Due to its rarity, heterogeneity, and a lack of a comprehensive understanding of the pathogenesis, little progress has been made in treatment and outcomes. The current review explores the past, present, and future of the understanding and treatment of this disease process. © 2012 Wiley Periodicals, Inc.
Keywords: treatment outcome; cancer surgery; overall survival; clinical feature; disease course; pathogenesis; review; cisplatin; doxorubicin; artificial embolism; diarrhea; disease classification; drug dose reduction; disease free survival; cancer staging; neurotoxicity; outcome assessment; cancer diagnosis; metastasis; anemia; etoposide; nausea; vomiting; weight reduction; steroid; adrenal cortex carcinoma; fever; cancer invasion; liver metastasis; lung metastasis; cancer size; hydrocortisone; management; outcomes; mitotane; adrenocortical carcinoma; 17 oxosteroid; adrenal cortex neoplasms; streptozocin; fludrocortisone; adrenalectomy; cushing syndrome; metastasis resection; virilization; feminization
Journal Title: Journal of Surgical Oncology
Volume: 106
Issue: 5
ISSN: 0022-4790
Publisher: Wiley Blackwell  
Date Published: 2012-10-01
Start Page: 586
End Page: 594
Language: English
DOI: 10.1002/jso.23112
PROVIDER: scopus
PUBMED: 22473597
DOI/URL:
Notes: --- - "Export Date: 1 October 2012" - "CODEN: JSONA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Murray F Brennan
    1059 Brennan